Causes for the development of lipodystrophy among HIV and AIDS patients
Journal: RUDN Journal of Medicine (Vol.22, No. 1)Publication Date: 2018-05-01
Authors : O Azovtseva; M Belous;
Page : 50-56
Keywords : HIV infection; lipodystrophy syndrome; antiretroviral therapy (ART);
Abstract
Today, about 35 million people worldwide are infected with HIV. These patients often develop lipid metabolism disorder called lipodystrophy syndrome. Various clinical features of lipodystrophy are peripheral fat loss in the lower limbs, face and buttocks (lipoatrophy); central adiposity, i.e. excess fat accumulation in the abdomen, breasts or dorsocervical region (lipohypertrophy); lipoma development. These types of redistribution of the adipose tissue occur in isolation as well as combined. The article examines the following causes of the development of lipodystrophy: HIV-associated lipodystrophy, HAART-associated lipodystrophy and lipodystrophy caused by age-related changes. It is also pointed out that redistribution of the adipose tissue is more common among the HIV-patients who have had PI-based ART or nucleoside reverse transcriptase inhibitors-based ART (NRTIs).
Other Latest Articles
- Proteins and microRNAs involved in papillomavirus infection
- Viral and bacterial coinfection as a global problem of modern medicine
- New predictive factors determining the clinical flow of oral mucositis in patients with plane-cellar cancer of oropharyngeal region
- Modern approaches to diagnosis and prediction of course of urothelial cancer
- MONO- AND MIXED-HERPESVIRUS INFECTIONS: ASSOCIATION WITH CLINICAL SYNDROMES OF IMMUNODEFICIENCY
Last modified: 2020-09-10 05:20:07